The first observation that several lung cancer types are characterized by the loss of the short arm of chromosome 3p, where the RARβ gene is localized, led to the investigation of retinoic acid receptors functionality in relation to the different responsiveness to retinoic acids’ treatments [141]. The gene discussed is RARB; the disease is lung cancer.